CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Randomized, Phase 2, Parallel, Dose-Ranging, Multicenter Study of Sotatercept for the Treatment of Patients With Anemia and Low or Intermediate-1 Risk Myelodysplastic Syndromes or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01736683
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:56.664890+00:00
Published At: 2019-06-13T00:00:00+00:00
Record Updated At: 2022-10-24
Results Posted At: 2019-06-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Anemia", "Myelodysplastic Syndromes", "Chronic Myelomonocytic Leukemia", "Low to Intermediate-1 MDS", "Myelodysplastic Syndromes (MDS)", "Chronic Myelomonocytic Leukemia (CMML)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-10-24"
protocolSection.identificationModule.nctId: "NCT01736683"
protocolSection.identificationModule.officialTitle: "An Open-label, Randomized, Phase 2, Parallel, Dose-Ranging, Multicenter Study of Sotatercept for the Treatment of Patients With Anemia and Low or Intermediate-1 Risk Myelodysplastic Syndromes or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-06-13"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.